M&A - PFIZER INC

Form Type: 11-K

Filing Date: 2025-06-16

Corporate Action: Acquisition

Type: Update

Accession Number: 000007800325000130

Filing Summary: This document is an annual report for the Pfizer Savings Plan for the fiscal year ended December 31, 2024. It presents the audited financial statements of the Plan, including a report on the net assets available for plan benefits and changes in net assets. The report indicates the assets of the Pfizer Savings Plan increased from approximately $19.7 billion in 2023 to over $22 billion in 2024. Significant transactions impacting the Plan include multiple acquisitions made by Pfizer, with the adoption and assumption of new retirement savings plans of acquired companies, such as ReViral Ltd., Global Blood Therapeutics, Inc., and Seagen Inc. In particular, the acquisition of Seagen in December 2023 added $564.9 million in account balances to the Plan. The report details investment gains and contributions, noting a net increase in the net assets of the Plan attributed to participant contributions and investment returns, while listing benefits paid to participants and administrative expenses as deductions from net assets. The document also outlines features of the Plan, including participant loans, matching contributions by Pfizer, and the investment options available to participants.